RELMADA THERAPEUTICS INC (RLMD)
US75955J4022 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 1.48M | 4.09M | 5.40M | 44.40M | 2.50M | |||
| Marketable Securities | 52.63M | 92.23M | 142.90M | 167.50M | 114.60M | |||
| Receivables | N/A | 0.00 | 500.00K | 100.00K | 100.00K | |||
| Other Current Assets | 1.58M | 1.19M | 4.00M | 11.30M | 900.00K | |||
| Total Current Assets | 55.70M | 97.51M | 152.90M | 223.30M | 118.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Other Non-Current Assets | 21.98K | 43.13K | 0.00 | 0.00 | 0.00 | |||
| Total Non-Current Assets | 21.98K | 43.12K | 0.00 | 0.00 | 100.00K | |||
| TOTAL ASSETS | 55.72M | 97.55M | 152.90M | 223.30M | 118.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 5.74M | 8.69M | 7.20M | 3.90M | 4.30M | |||
| Accounts Payable | 2.35M | 3.51M | 5.30M | 11.20M | 8.30M | |||
| Other Current Liabilities | 12.56K | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 8.10M | 12.19M | 12.50M | 15.10M | 12.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 8.10M | 12.19M | 12.50M | 15.10M | 12.60M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -622.22M | -560.90M | -462.10M | -305.10M | -179.30M | |||
| Additional Paid In Capital | 669.82M | 646.23M | 602.50M | 513.30M | 284.90M | |||
| Common Shares | 30.17K | 30.10K | 0.00 | 0.00 | 0.00 | |||
| Shares Outstanding | 30.17M | 30.10M | 30.10M | 27.70M | 16.30M | |||
| Tangible Book Value per Share | 1.58 | 2.84 | 4.66 | 7.52 | 6.48 | |||
| Total Shareholders' Equity | 47.63M | 85.36M | 140.40M | 208.30M | 105.60M | |||
| TOTAL LIABILITIES AND EQUITY | 55.72M | 97.55M | 152.90M | 223.30M | 118.20M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 6.88 | 8.00 | 12.23 | 14.79 | 9.37 | |||
| Return On Assets (ROA) | -155.21% | -101.27% | -102.71% | -56.31% | -50.30% | |||
| Return On Equity (ROE) | -181.60% | -115.74% | -111.85% | -60.37% | -56.31% | |||
All data in USD , ROIC based on taxRate of 0.21